Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Zhongshan Urology Hospital is a specialized healthcare institution located in Shenzhen, China, primarily focused on reproductive medicine and urology. Founded in 1986 by Professor Mei Hua, the hospital has evolved into a leading center for Assisted Reproductive Technology (ART), including In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI). It is particularly renowned for its research and clinical applications in reproductive immunology, aiming to improve success rates for patients with recurrent implantation failure. In 2020, the hospital was fully integrated into Jinxin Fertility, a major provider of assisted reproductive services in China and the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Zhongshan Urology Hospital.